Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Ultragenyx Pharmaceutical Inc    RARE

ULTRAGENYX PHARMACEUTICAL INC (RARE)
My previous session
Most popular
  Report  
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Upcoming events on ULTRAGENYX PHARMACEUTICAL
11/12/18 Q3 2018 Earnings Release (Projected)
02/20/19 FY 2018 Earnings Release (Projected)
05/06/19 Q1 2019 Earnings Release (Projected)
08/05/19 Interim 2019 Earnings Release (Projected)
Past events on ULTRAGENYX PHARMACEUTICAL
09/27/18 | 02:00pm Jefferies Gene Therapy Summit
09/13/18 | 10:40pm Morgan Stanley Global Health Care Conference
09/06/18 | 04:15pm Robert W. Baird Healthcare Conference
08/02/18 Interim 2018 Earnings Release
Upcoming sector events for ULTRAGENYX PHARMACEUTICAL
10/21/18 | 12:45pm INCYTE CORPORATION : European Society for Medical Oncology Meeting - Abstract #756P
10/21/18 | 12:45pm REGENERON PHARMACEUTICALS INC : European society for medical oncology meeting - abstract : 1292p
10/22/18 | 12:45pm NEKTAR THERAPEUTICS : European Society for Medical Oncology Meeting - Poster #362TiP
10/22/18 | 03:00pm IQVIA HOLDINGS INC : Q3 2018 Earnings Call
Past sector events for ULTRAGENYX PHARMACEUTICAL
10/20/18 | 12:30pm GENMAB A/S : European society for medical oncology meeting - abstract #: 963p
10/20/18 | 12:30pm REGENERON PHARMACEUTICALS INC : European society for medical oncology meeting - abstract : 1162p
10/20/18 | 12:30pm REGENERON PHARMACEUTICALS INC : European Society for Medical Oncology Meeting - Abstract 1151P
10/20/18 | 12:30pm SEATTLE GENETICS, INC. : European society for medical oncology meeting - abstract #: 963p
Annual publications
Previous yearNext Year
Annual results2015201620172018 (e)2019 (e)
Sales
Million $
Released
Forecast
Spread


0,13
1,07
-88%
2,61
0,43
501%

56,1

106
Operating income (EBITDA)
Million $
Released
Forecast
Spread
-146
-133
-9,8%
-245
-239
-2,4%
-323
-319
-1,4%

-380

-328
Operating profit (EBIT)
Million $
Released
Forecast
Spread
-148
-136
-9,0%
-248
-245
-1,3%
-329
-318
-3,3%

-390

-367
Pre-Tax Profit (EBT)
Million $
Released
Forecast
Spread
-146
-134
-8,3%
-246
-244
-0,80%
-318
-308
-3,5%

-227

-358
Net income
Million $
Released
Forecast
Spread
-146
-135
-8,2%
-246
-244
-0,82%
-302
-299
-1,0%

-227

-364
EPS
 $
Released
Forecast
Spread
-3,96
-3,62
-9,5%
-6,21
-6,19
-0,36%
-7,12
-7,03
-1,3%

-4,39

-6,41
Announcement Date02/25/201602/16/201702/20/2018

Quarterly / Semiannualy publications
Previous yearPrevious periodNext periodNext Year
Quarterly resultsQ4
2017
Q1
2018
Q2
2018
Q3
2018 (e)
Q4
2018 (e)
Sales
Million $
Released
Forecast
Spread
2,41
0,18
1 230%
10,7
52,9
-80%
12,8
5,42
136%

11,1

20,0
Operating income (EBITDA)
Million $
Released
Forecast
Spread
-94,3
-85,9
-9,8%
-90,3
-24,5
-268%
-88,8
-108
18%

-95,4

-95,9
Operating profit (EBIT)
Million $
Released
Forecast
Spread
-96,8
-84,5
-15%
-96,5
-33,8
-185%
-94,9
-103
8,0%

-101

-95,7
Pre-Tax Profit (EBT)
Million $
Released
Forecast
Spread
-97,9
-84,4
-16%
30,3
-15,0
302%
-52,6
-102
48%

-99,6

-97,3
Net income
Million $
Released
Forecast
Spread
-81,7
-84,9
3,7%
30,3
-17,2
275%
-52,7
-102
48%

-99,6

-97,3
EPS
 $
Released
Forecast
Spread
-1,89
-1,97
4,1%
0,62
-0,42
247%
-1,06
-2,08
49%

-1,96

-1,89
Announcement Date02/20/201805/07/201808/02/2018

© 2018 Thomson Reuters
© 2018 Factset
Operating profit (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
Operating profit (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise